The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 555.00
Bid: 455.00
Ask: 598.00
Change: 0.00 (0.00%)
Spread: 143.00 (31.429%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 555.00
BAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of Frazer-Nash and half year trading update

21 Oct 2021 07:00

RNS Number : 7479P
Babcock International Group PLC
21 October 2021
 

Completion of the sale of Frazer-Nash and half year trading update

 

21 October 2021

 

Babcock International Group PLC ("Babcock" or "the Group") announces the completion of the sale of Frazer-Nash and provides a short trading update for the half year ending 30 September 2021 (HY22).

 

Completion of the sale of Frazer-Nash

On 20 October 2021, Babcock completed the sale of Frazer-Nash Consultancy to KBR for a cash consideration of £293 million before adjustments and transaction costs. This sale forms part of our portfolio realignment, which aims to generate at least £400 million of proceeds, the majority of which will be used to reduce the Group's net debt. The Consultancy was part of Babcock's Marine sector and had revenue of £101 million in FY21 (FY20: £102 million), with profit before interest and tax of £14 million (FY20: £17 million).

 

Trading update for HY22

Trading for the Group in the first half of the year was in line with our expectations and our full year outlook remains unchanged.

 

The headline financial performance for the half year ended 30 September 2021, based on our draft management accounts, shows revenue of £2,228 million with underlying operating profit of £115 million.

 

Based on our draft management accounts, the Group's net debt at 30 September 2021 was £1,347 million (31 March 2021: £1,354 million), and £938 million excluding operating leases (31 March 2021: £772 million). The Group's net debt to EBITDA ratio (covenant basis) at 30 September 2021 was 2.8 times (31 March 2021: 2.5x).

 

 

For further information:

Simon McGough, Director of Investor Relations

+44 (0)7850 978 741

Kate Hill, Group Director of Communications

+44 (0)20 7355 5312

Tulchan Communications

Olivia Peters / Harry Cameron

+44 (0)20 7353 4200  

 

 

Note

The financial comparator figures for the half year ended 30 September 2020 (HY21) will be restated to include the results of our Contract Profitability and Balance Sheet review outlined alongside our FY21 results on 30 July 2021. These restatements will be made available ahead of the publication of our half year results on 7 December 2021.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZMZGZGRGMZZ
Date   Source Headline
20th Sep 20177:00 amRNSTrading Update
8th Sep 201710:41 amRNSPublication of a Prospectus
17th Aug 201711:37 amRNSHolding(s) in Company
16th Aug 201711:54 amRNSDirector/PDMR Shareholding
13th Jul 20173:48 pmRNSResult of AGM
13th Jul 20177:00 amRNSAnnual General Meeting Trading Update
29th Jun 20177:00 amRNSContract Award
27th Jun 201712:32 pmRNSDirector/PDMR Shareholding
22nd Jun 201712:00 pmRNSDirector/PDMR Shareholding
20th Jun 201711:53 amRNSDirector/PDMR Shareholding
19th Jun 201710:53 amRNSDirector/PDMR Shareholding
15th Jun 20173:58 pmRNSDirector/PDMR Shareholding
13th Jun 20175:08 pmRNSNotice of AGM
7th Jun 20175:24 pmRNSHolding(s) in Company
7th Jun 20174:55 pmRNSDirector/PDMR Shareholding
7th Jun 20171:17 pmRNSDirector/PDMR Shareholding
1st Jun 201710:11 amRNSPublication of Final Terms
30th May 20175:23 pmRNSDirector/PDMR Shareholding
24th May 20173:43 pmRNSHolding(s) in Company
24th May 20177:00 amRNSFinal Results
19th May 20179:34 amRNSHolding(s) in Company
2nd May 20179:59 amRNSHolding(s) in Company
13th Apr 201710:09 amRNSHolding(s) in Company
13th Apr 20178:55 amRNSHolding(s) in Company
11th Apr 20179:26 amRNSHolding(s) in Company
3rd Apr 20177:00 amRNSPreferred bidder for Royal Navy support contract
29th Mar 20174:38 pmRNSHolding(s) in Company
27th Mar 20173:01 pmRNSDirector/PDMR Shareholding
27th Mar 20172:58 pmRNSDirector/PDMR Shareholding
27th Mar 201712:10 pmRNSDirector/PDMR Shareholding
27th Mar 20177:22 amRNSMagnox decommissioning contract
24th Mar 20179:54 amRNSHolding(s) in Company
14th Mar 20177:00 amRNSRealignment Presentation
28th Feb 20177:00 amRNSTrading Update
24th Feb 20171:00 pmRNSHolding(s) in Company
15th Feb 201712:11 pmRNSHolding(s) in Company
9th Feb 20174:53 pmRNSHolding(s) in Company
7th Feb 20175:00 pmRNSDirector Declaration
3rd Feb 20175:23 pmRNSHolding(s) in Company
20th Jan 201710:01 amRNSDirector/PDMR Shareholding
5th Jan 20179:00 amRNSFOMEDEC Contract Award
12th Dec 20161:19 pmRNSDirector Declaration
28th Nov 20164:18 pmRNSHolding(s) in Company
28th Nov 201611:07 amRNSDirector/PDMR Shareholding
23rd Nov 20163:48 pmRNSHolding(s) in Company
23rd Nov 20162:56 pmRNSHolding(s) in Company
22nd Nov 20167:00 amRNSHalf-year Report
21st Nov 201611:13 amRNSContract Award
21st Oct 20164:11 pmRNSHolding(s) in Company
17th Oct 20167:00 amRNSCapital Markets Day site visit

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.